Mulder G J, Weitering J G, Scholtens E, Dawson J R, Pang K S
Biochem Pharmacol. 1984 Oct 1;33(19):3081-7. doi: 10.1016/0006-2952(84)90613-0.
The phenolic compound, harmol, is metabolized by sulfation and glucuronidation in the rat in vivo. In the present study, various harmol infusion rates into the jugular vein were used to delineate first-order conditions whereby total body clearance was maximal and constant; at low infusion rates the steady state harmol concentration in blood varied proportionally with the infusion rate. At infusion rates of 167 nmole/min and below, the steady state clearance of harmol was 60 ml/min or 200 ml/min/kg. Because this value for total body clearance greatly exceeded the value for hepatic blood flow rate (20 ml/min for a 300 g rat), considerable extrahepatic conjugation of harmol was suggested. At higher harmol infusion rates the total clearance decreased. Since an intraportal infusion of 167 nmole/min to the rat yielded, during steady state, the same arterial harmol blood concentration as a 52 nmole/min jugular infusion, the hepatic extraction ratio of harmol in vivo was 0.7. Extrahepatic clearance, therefore, constituted about 77% of total body clearance (after taking the difference between total body clearance and hepatic clearance). Total sulfation clearance was 52 ml/min, and greatly exceed the value for hepatic clearance (14 ml/min). Extrahepatic clearance for sulfation (at least 38 ml/min) therefore accounted for a major proportion of the sulfation activity. Blood platelets did not seem to contribute to sulfation or glucuronidation in vivo.
酚类化合物哈尔满在大鼠体内通过硫酸化和葡萄糖醛酸化进行代谢。在本研究中,采用不同的哈尔满颈静脉输注速率来确定一级条件,即全身清除率最大且恒定;在低输注速率下,血液中哈尔满的稳态浓度与输注速率成比例变化。在输注速率为167纳摩尔/分钟及以下时,哈尔满的稳态清除率为60毫升/分钟或200毫升/分钟/千克。由于该全身清除率值大大超过肝血流量值(300克大鼠为20毫升/分钟),提示哈尔满存在大量肝外结合。在较高的哈尔满输注速率下,总清除率降低。由于向大鼠门静脉输注167纳摩尔/分钟在稳态时产生的动脉血哈尔满浓度与颈静脉输注52纳摩尔/分钟时相同,哈尔满在体内的肝提取率为0.7。因此,肝外清除率约占全身清除率的77%(在计算全身清除率与肝清除率之差后)。总硫酸化清除率为52毫升/分钟,大大超过肝清除率值(14毫升/分钟)。因此,硫酸化的肝外清除率(至少38毫升/分钟)占硫酸化活性的主要部分。血小板似乎在体内对硫酸化或葡萄糖醛酸化没有贡献。